Arrowhead
is a California-based pharmaceutical company that researches and develops RNAi-based therapeutics for the treatment of genetic diseases... Read moreArrowhead
is a California-based pharmaceutical company that researches and develops RNAi-based therapeutics for the treatment of genetic diseases... Read more
President & CEO
Christopher Anzalone
News
Partnership
Feb 10, 2025
Marketscreener
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
Regulatory
Dec 03, 2024
StreetInsider
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
Conference Presentation
Nov 04, 2024
Business Wire
Arrowhead Pharmaceuticals to Participate in Upcoming November 2024 Conferences
Funding
Aug 07, 2024
sixthstreet.com
Arrowhead received $400M in Post-IPO Debt Funding
Arrowhead Competitors
1
2
3
4
5
6
7